Connect with us

Health

BU researchers find how SARS-CoV-2 infection may drive deadly lung inflammation – News-Medical.Net

Responding to the COVID-19 pandemic caused by the novel coronavirus, SARS-CoV-2, requires models that can duplicate disease development in humans, identify potential targets and enable drug testing.

Published

on

Reviewed by Emily Henderson, B.Sc.Sep 21 2020
Responding to the COVID-19 pandemic caused by the novel coronavirus, SARS-CoV-2, requires models that can duplicate disease development in humans, identify potential targets and enable drug testing. Specifically, access to primary human lung in vitro model systems is a priority since a variety of respiratory epithelial cells are the proposed targets of viral entry.
Now, a team of infectious disease, pulmonary and regenerative medicine researchers a…

Click here to view the original article.